Anthem Biosciences Listing Preview: Anthem Biosciences Ltd., which is a fully integrated operations encompassing drug discovery, development, and manufacturing processes, is set to list on BSE and NSE today (Monday, July 21, 2025). The offer for sale IPO, which opened on July 14 and closed on July 16, has an issue price of Rs 570…
Anthem Biosciences IPO Allotment: After a blockbuster response from investors, all eyes are now on the IPO allotment of Anthem Biosciences, which is set to be finalised on Wednesday, July 17. The IPO, which opened on July 14 and closed on July 16, saw massive demand, subscribing 63.86 times overall. According to BSE data, the…
The initial public offering (IPO) of Anthem Biosciences on its second day of bidding process, subscribed 3.29 times, with total bids received for 14,48,55,464 shares against 4,40,70,682 shares on offer, according to BSE data. The Qualified Institutional Buyers (QIBs) segment received bids for 74,06,464 shares against 1,25,43,518 shares on offer, translating to a subscription of 0.59…
The IPO market is set for another active spell in the week beginning July 14, as three new issues prepare to hit the street across mainboard and SME segments. The combined fundraising target stands at over Rs 3,600 crore, led by a much-anticipated pharma listing and supported by consumer and manufacturing plays in the SME…